vs
Bioventus Inc.（BVS）与REPUBLIC BANCORP INC（RBCAA）财务数据对比。点击上方公司名可切换其他公司
Bioventus Inc.的季度营收约是REPUBLIC BANCORP INC的1.7倍（$157.9M vs $94.3M），REPUBLIC BANCORP INC净利率更高（24.2% vs 9.3%，领先14.9%），REPUBLIC BANCORP INC同比增速更快（5.3% vs 2.8%），REPUBLIC BANCORP INC自由现金流更多（$161.1M vs $37.4M），过去两年Bioventus Inc.的营收复合增速更高（10.4% vs -11.5%）
Bioventus Inc.是一家全球化医疗技术企业，专注于骨科生物制剂领域，研发并商业化促进骨关节愈合、肌肉骨骼疼痛管理及再生护理的相关产品，服务全球多地的骨科临床医师、康复师及患者群体。
肯塔基州共和银行是美国的一家区域性银行控股企业，提供零售及商业银行全品类服务，涵盖个人存贷款、企业融资、按揭产品及财富管理解决方案，主要服务肯塔基州及周边州的个人消费者和中小企业客户。
BVS vs RBCAA — 直观对比
营收规模更大
BVS
是对方的1.7倍
$94.3M
营收增速更快
RBCAA
高出2.5%
2.8%
净利率更高
RBCAA
高出14.9%
9.3%
自由现金流更多
RBCAA
多$123.7M
$37.4M
两年增速更快
BVS
近两年复合增速
-11.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $157.9M | $94.3M |
| 净利润 | $14.8M | $22.8M |
| 毛利率 | 68.9% | — |
| 营业利润率 | 12.3% | 29.3% |
| 净利率 | 9.3% | 24.2% |
| 营收同比 | 2.8% | 5.3% |
| 净利润同比 | 3902.8% | 20.0% |
| 每股收益（稀释后） | $0.21 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BVSRBCAA
| Q4 25 | $157.9M | $94.3M | ||
| Q3 25 | $138.7M | $93.5M | ||
| Q2 25 | $147.7M | $93.8M | ||
| Q1 25 | $123.9M | $135.8M | ||
| Q4 24 | $153.6M | $89.5M | ||
| Q3 24 | $139.0M | $88.1M | ||
| Q2 24 | $151.2M | $86.9M | ||
| Q1 24 | $129.5M | $120.3M |
净利润BVSRBCAA
| Q4 25 | $14.8M | $22.8M | ||
| Q3 25 | $3.2M | $29.7M | ||
| Q2 25 | $7.5M | $31.5M | ||
| Q1 25 | $-2.6M | $47.3M | ||
| Q4 24 | $-388.0K | $19.0M | ||
| Q3 24 | $-5.2M | $26.5M | ||
| Q2 24 | $-25.7M | $25.2M | ||
| Q1 24 | $-4.9M | $30.6M |
毛利率BVSRBCAA
| Q4 25 | 68.9% | — | ||
| Q3 25 | 68.0% | — | ||
| Q2 25 | 69.1% | — | ||
| Q1 25 | 67.0% | — | ||
| Q4 24 | 66.8% | — | ||
| Q3 24 | 67.3% | — | ||
| Q2 24 | 68.5% | — | ||
| Q1 24 | 68.3% | — |
营业利润率BVSRBCAA
| Q4 25 | 12.3% | 29.3% | ||
| Q3 25 | 8.1% | 40.4% | ||
| Q2 25 | 12.4% | 43.0% | ||
| Q1 25 | 3.9% | 44.1% | ||
| Q4 24 | 5.0% | 25.8% | ||
| Q3 24 | 2.6% | 38.4% | ||
| Q2 24 | -20.8% | 37.0% | ||
| Q1 24 | 3.8% | 32.2% |
净利率BVSRBCAA
| Q4 25 | 9.3% | 24.2% | ||
| Q3 25 | 2.3% | 31.8% | ||
| Q2 25 | 5.1% | 33.5% | ||
| Q1 25 | -2.1% | 34.8% | ||
| Q4 24 | -0.3% | 21.2% | ||
| Q3 24 | -3.7% | 30.1% | ||
| Q2 24 | -17.0% | 29.0% | ||
| Q1 24 | -3.8% | 25.4% |
每股收益（稀释后）BVSRBCAA
| Q4 25 | $0.21 | — | ||
| Q3 25 | $0.05 | — | ||
| Q2 25 | $0.11 | — | ||
| Q1 25 | $-0.04 | — | ||
| Q4 24 | $0.00 | — | ||
| Q3 24 | $-0.08 | — | ||
| Q2 24 | $-0.40 | — | ||
| Q1 24 | $-0.08 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $51.2M | $220.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $184.1M | $1.1B |
| 总资产 | $683.6M | $7.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BVSRBCAA
| Q4 25 | $51.2M | $220.0M | ||
| Q3 25 | $42.2M | $484.2M | ||
| Q2 25 | $32.9M | $484.8M | ||
| Q1 25 | $22.8M | $793.0M | ||
| Q4 24 | $41.6M | $432.2M | ||
| Q3 24 | $43.1M | $530.9M | ||
| Q2 24 | $32.0M | $400.1M | ||
| Q1 24 | $25.2M | $546.4M |
股东权益BVSRBCAA
| Q4 25 | $184.1M | $1.1B | ||
| Q3 25 | $166.1M | $1.1B | ||
| Q2 25 | $161.2M | $1.1B | ||
| Q1 25 | $148.1M | $1.0B | ||
| Q4 24 | $147.9M | $992.0M | ||
| Q3 24 | $148.7M | $979.7M | ||
| Q2 24 | $150.9M | $955.4M | ||
| Q1 24 | $171.3M | $935.6M |
总资产BVSRBCAA
| Q4 25 | $683.6M | $7.0B | ||
| Q3 25 | $701.6M | $7.0B | ||
| Q2 25 | $706.8M | $7.0B | ||
| Q1 25 | $691.4M | $7.1B | ||
| Q4 24 | $728.0M | $6.8B | ||
| Q3 24 | $769.5M | $6.7B | ||
| Q2 24 | $792.2M | $6.6B | ||
| Q1 24 | $794.2M | $6.9B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $38.0M | $168.2M |
| 自由现金流经营现金流 - 资本支出 | $37.4M | $161.1M |
| 自由现金流率自由现金流/营收 | 23.7% | 170.9% |
| 资本支出强度资本支出/营收 | 0.4% | 7.5% |
| 现金转化率经营现金流/净利润 | 2.57× | 7.37× |
| 过去12个月自由现金流最近4个季度 | $72.1M | $288.6M |
8季度趋势，按日历期对齐
经营现金流BVSRBCAA
| Q4 25 | $38.0M | $168.2M | ||
| Q3 25 | $30.1M | $33.3M | ||
| Q2 25 | $25.9M | $8.4M | ||
| Q1 25 | $-19.3M | $93.2M | ||
| Q4 24 | $19.3M | $149.0M | ||
| Q3 24 | $10.3M | $51.3M | ||
| Q2 24 | $15.2M | $4.0M | ||
| Q1 24 | $-6.0M | $71.2M |
自由现金流BVSRBCAA
| Q4 25 | $37.4M | $161.1M | ||
| Q3 25 | $29.6M | $30.8M | ||
| Q2 25 | $25.3M | $5.2M | ||
| Q1 25 | $-20.2M | $91.6M | ||
| Q4 24 | $18.7M | $143.2M | ||
| Q3 24 | $10.3M | $49.8M | ||
| Q2 24 | $15.1M | $2.7M | ||
| Q1 24 | $-6.3M | $69.1M |
自由现金流率BVSRBCAA
| Q4 25 | 23.7% | 170.9% | ||
| Q3 25 | 21.4% | 32.9% | ||
| Q2 25 | 17.1% | 5.5% | ||
| Q1 25 | -16.3% | 67.4% | ||
| Q4 24 | 12.2% | 160.0% | ||
| Q3 24 | 7.4% | 56.5% | ||
| Q2 24 | 10.0% | 3.1% | ||
| Q1 24 | -4.9% | 57.5% |
资本支出强度BVSRBCAA
| Q4 25 | 0.4% | 7.5% | ||
| Q3 25 | 0.3% | 2.6% | ||
| Q2 25 | 0.5% | 3.5% | ||
| Q1 25 | 0.7% | 1.2% | ||
| Q4 24 | 0.4% | 6.5% | ||
| Q3 24 | 0.0% | 1.7% | ||
| Q2 24 | 0.1% | 1.5% | ||
| Q1 24 | 0.2% | 1.7% |
现金转化率BVSRBCAA
| Q4 25 | 2.57× | 7.37× | ||
| Q3 25 | 9.54× | 1.12× | ||
| Q2 25 | 3.48× | 0.27× | ||
| Q1 25 | — | 1.97× | ||
| Q4 24 | — | 7.84× | ||
| Q3 24 | — | 1.93× | ||
| Q2 24 | — | 0.16× | ||
| Q1 24 | — | 2.33× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BVS
| Pain Treatments | $71.1M | 45% |
| Surgical Solutions | $48.9M | 31% |
| Restorative Therapies | $19.5M | 12% |
| Other | $18.4M | 12% |
RBCAA
暂无分部数据
